ARTICLE SUMMARY:
To understand how changing guidelines and clinical practice have impacted TAVR’s utilization compared to SAVR across age groups over the last decade and what they portend for the future, Health Advances conducted a comprehensive analysis of real-world data of US aortic valve replacement procedures.
Transcatheter aortic valve replacement (TAVR) has been one of the fastest growing medtech markets for the last decade, and as it begins to mature, predictions vary as to the remaining potential for penetration into total aortic valve replacement (AVR) procedures. With frequent changes in recommendations and guidelines, real-world data can help us understand shifts in the age demographics of patients who undergo TAVR versus surgical aortic valve replacement (SAVR) and how these trends might point to expected changes in future market dynamics.
